Elevation Oncology, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income (expense), net
Loss on extinguishment of debt
Total other income (expense), net
Loss before income taxes
Income tax expense
Net loss
Net loss per share
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)
Other comprehensive income:
Unrealized gain on marketable securities
Total other comprehensive income
Total comprehensive loss

Comments